DANZITEN vs QINLOCK

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 19, 2026·How we rate

Possible drug interaction. DANZITEN and QINLOCK are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	DANZITEN	QINLOCK
Rating	70/100	New
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	NILOTINIB TARTRATE	RIPRETINIB
Manufacturer	Azurity	Deciphera Pharms
Dosage forms	Tablet	Tablet
Drug class	Kinase Inhibitor	—
Boxed warning	Boxed warning	None
Treats	Accelerated Phase Myeloid Leukemia, Chronic-Phase Myeloid Leukemia, Gastrointestinal Stromal Tumors	Gastrointestinal Stromal Tumors

danziten qinlock

Rating

70/100

New

Pharmacy pays

—

Type

Active ingredient

NILOTINIB TARTRATE

RIPRETINIB

Manufacturer

Azurity

Deciphera Pharms

Dosage forms

Tablet

Drug class

Kinase Inhibitor

—

Boxed warning

None

Treats

Accelerated Phase Myeloid Leukemia, Chronic-Phase Myeloid Leukemia, Gastrointestinal Stromal Tumors

Gastrointestinal Stromal Tumors

Frequently asked questions

What is the difference between Danziten and Qinlock?

Danziten contains Nilotinib Tartrate, while Qinlock contains Ripretinib — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.